• WCNDD and Ono Pharmaceutical Publish Key TREK Channel Study

  • Warren Center for Neuroscience Drug Discovery researchers create new compound to potentially treat negative and positive symptoms of schizophrenia

  • Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

Discoveries in Medicine - Vanderbilt Health Update
Bruce Melancon Bruce Melancon

Discoveries in Medicine - Vanderbilt Health Update

More on our ongoing collaboration with W. David Merryman, Walters Family Professor of Biomedical Engineering at VU, on addressing pulmonary arterial hypertension (PAH) using peripherally restricted 5-HT2B antagonists.

Read More